학술논문

Efficacy and Safety of Regdanvimab (CT-P59): A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial in Outpatients With Mild-to-Moderate Coronavirus Disease 2019

Document Type

Article

Author

Streinu-Cercel, A.; Sandulescu, O.; Preotescu, L.-L.; Streinu-Cercel, A.; Kim, J.Y.; Jang, Y.R.; Kim, Y.-S.; Cheon, S.; Lee, S.J.; Kim, S.H.; Chang, I.; Suh, J.H.; Lee, S.G.; Kim, M.R.; Chung, D.R.; Kim, H.N.; Eom, J.S.

Source

In: Open Forum Infectious Diseases. (Open Forum Infectious Diseases, 1 April 2022, 9(4))

Subject

Language

English

ISSN

23288957

Online Access

Full Text (Gale Academic Onefile) Open Access (OUP) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일

부산대학교 도서관

Online Access

메일 발송